CEACAM5 and gastric cancer: In this regard, there is a growing focus on miRNAs (particularly miR-106) in plasma/gastric juice or other fluids to establish non-invasive ways to detect early-stage gastric cancer, as potential biomarkers that can add specificity to the traditional markers CEA and CA 19-9, with many biological benefits and clinical potential.